X0609 4 2026-05-15 0 0002019410 Caris Life Sciences, Inc. CAI 0001034380 HALBERT DAVID D false C/O CARIS LIFE SCIENCES, INC. 750 W. JOHN CARPENTER FREEWAY, SUITE 800 IRVING TX 75039 1 1 1 0 See Remarks 0 Common Stock 2026-05-15 4 F 0 40712 15.25 D 2574533 D Common Stock 121025002 I See Footnotes Shares withheld for the payment of taxes on the vesting and settlement of RSUs. The Common Stock reported herein includes (i) 76,261,532 shares of Common Stock held by Caris Halbert, L.P., (ii) 8,528,805 shares of Common Stock held by ADAPT I Ltd., (iii) 8,414,427 shares of Common Stock held by Carisome I, L.P., (iv) 645,149 shares of Common Stock held by Caris Investment II Ltd, (v) 2,175,089 shares of Common Stock held by Caris Investment III Ltd, and (vi) 25,000,000 shares held by Halbert Family Capital, LLC. Caris Investment Management, LLC is the general partner of each of Caris Halbert, L.P., Caris Investment II Ltd., and Caris Investment III Ltd. Two family trusts are separately the general partner of ADAPT I Ltd. and the managing general partner of Carisome I, L.P., respectively. Caris Halbert, L.P. is the managing member of Halbert Family Capital, LLC. David Dean Halbert is the managing member of Caris Investment Management, LLC and the trustee of each of the two family trusts, and in such capacities, has voting and investment power with respect to the shares held by each of the foregoing entities. Mr. Halbert disclaims beneficial ownership except to the extent of his pecuniary interest therein. Founder, Chairman, and Chief Executive Officer /s/ J. Russel Denton, Attorney-in-Fact 2026-05-18